Key facts
- It has raised $4.7M across 1 recorded rounds; the latest was Seed Round ($2.9M) in May 2022.
- Notable investors include Plug and Play Tech Center, Mana Ventures, Gaingels, Keiretsu Forum, 2468 Ventures — 12 tracked in total.
- InSite Health has filed 1 Form D with the SEC, most recently Feb 2024 ($2.9M sold to 21 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for InSite Health
Funding rounds
1 roundsAbout InSite Health
Provider of comprehensive hybrid telepsychiatry services intended to deliver evidence-based mental health care in person and via telehealth. The company provides treatment for mental health conditions such as anxiety disorders, post-traumatic stress disorder, depression, attention deficit hyperactivity disorder, behavioral disorders, psychiatric care and in-person sessions through teletherapy, enabling children and adults to get medical visits and psychiatric services at their convenience.
- Sector
- Healthcare
- HQ
- Marlton, NJ, United States
- Founded
- 2022
- Employees
- 34
- Website
- insitehealth.net/
- Ownership
- Privately Held (backing)
InSite Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in InSite Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on InSite Health in its N-PORT filings yet. We sweep new filings monthly.